Brief: GNI Group says investigational new drug approval by CFDA

GNI

08/09/2016 09:26

Sept 8 (Reuters) - GNI Group Ltd  2160.T : 
     
    * Says China Food and Drug Administration (CFDA) has 
approved the Investigational New Drug (IND) application for a 
drug for treatment of interstitial lung disease associated with 
connective tissue disease 
     
     
    Source text in Japanese: https://goo.gl/mT6fqP 
    Further company Coverage:  2160.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724; 
Reuters Messaging: qiujing.li.thomsonreuters.com@reuters.net))